315 related articles for article (PubMed ID: 8568827)
1. Synthesis and biological activity of folic acid and methotrexate analogues containing L-threo-(2S,4S)-4-fluoroglutamic acid and DL-3,3-difluoroglutamic acid.
Hart BP; Haile WH; Licato NJ; Bolanowska WE; McGuire JJ; Coward JK
J Med Chem; 1996 Jan; 39(1):56-65. PubMed ID: 8568827
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of DL-4,4-difluoroglutamic acid and DL-gamma,gamma-difluoromethotrexate.
Tsukamoto T; Kitazume T; McGuire JJ; Coward JK
J Med Chem; 1996 Jan; 39(1):66-72. PubMed ID: 8568828
[TBL] [Abstract][Full Text] [Related]
3. DL-beta,beta-difluoroglutamic acid mediates position-dependent enhancement or termination of pteroylpoly(gamma-glutamate) synthesis catalyzed by folylpolyglutamate synthetase.
McGuire JJ; Hart BP; Haile WH; Rhee MS; Galivan J; Coward JK
Arch Biochem Biophys; 1995 Aug; 321(2):319-28. PubMed ID: 7646057
[TBL] [Abstract][Full Text] [Related]
4. Biological properties of fluoroglutamate-containing analogs of folates and methotrexate with altered capacities to form poly (gamma-glutamate) metabolites.
McGuire JJ; Hart BP; Haile WH; Magee KJ; Rhee M; Bolanowska WE; Russell C; Galivan J; Paul B; Coward JK
Biochem Pharmacol; 1996 Oct; 52(8):1295-303. PubMed ID: 8937438
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
Mao Z; Pan J; Kalman TI
J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
[TBL] [Abstract][Full Text] [Related]
6. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of N alpha-(4-amino-4-deoxy-10-methylpteroyl)-DL-4,4-difluoroornithine.
Tsukamoto T; Haile WH; McGuire JJ; Coward JK
J Med Chem; 1996 Jun; 39(13):2536-40. PubMed ID: 8691451
[TBL] [Abstract][Full Text] [Related]
8. Mechanism-based inhibitors of folylpoly-gamma-glutamate synthetase and gamma-glutamyl hydrolase: control of folylpoly-gamma-glutamate homeostasis as a drug target.
Coward JK; McGuire JJ
Vitam Horm; 2008; 79():347-73. PubMed ID: 18804701
[TBL] [Abstract][Full Text] [Related]
9. Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
Rosowsky A; Vaidya CM; Bader H; Wright JE; Teicher BA
J Med Chem; 1997 Jan; 40(3):286-99. PubMed ID: 9022795
[TBL] [Abstract][Full Text] [Related]
10. Biochemical and growth inhibitory effects of the erythro and threo isomers of gamma-fluoromethotrexate, a methotrexate analogue defective in polyglutamylation.
McGuire JJ; Graber M; Licato N; Vincenz C; Coward JK; Nimec Z; Galivan J
Cancer Res; 1989 Aug; 49(16):4517-25. PubMed ID: 2472880
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
Rosowsky A; Forsch RA; Wright JE
J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
[TBL] [Abstract][Full Text] [Related]
12. Effect of bridge region variation on antifolate and antitumor activity of classical 5-substituted 2,4-diaminofuro[2,3-d]pyrimidines.
Gangjee A; Devraj R; McGuire JJ; Kisliuk RL
J Med Chem; 1995 Sep; 38(19):3798-805. PubMed ID: 7562910
[TBL] [Abstract][Full Text] [Related]
13. Lipophilic conjugates of methotrexate with short-chain alkylamino acids as DHFR inhibitors. Synthesis, biological evaluation, and molecular modeling.
Pignatello R; Guccione S; Forte S; Di Giacomo C; Sorrenti V; Vicari L; Uccello Barretta G; Balzano F; Puglisi G
Bioorg Med Chem; 2004 Jun; 12(11):2951-64. PubMed ID: 15142554
[TBL] [Abstract][Full Text] [Related]
14. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
Samuels LL; Moccio DM; Sirotnak FM
Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
[TBL] [Abstract][Full Text] [Related]
15. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary in vitro screening of lipophilic alpha, gamma-bis(amides) as potential prodrugs of methotrexate.
Pignatello R; Sorrenti V; Spampinato G; Pecora T; Panico A; Di Giacomo C; Fresta M; Vanella A; Puglisi G
Anticancer Drug Des; 1996 Apr; 11(3):253-64. PubMed ID: 8663912
[TBL] [Abstract][Full Text] [Related]
17. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
[TBL] [Abstract][Full Text] [Related]
18. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
[TBL] [Abstract][Full Text] [Related]
19. 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase.
Rosowsky A; Forsch RA; Null A; Moran RG
J Med Chem; 1999 Sep; 42(18):3510-9. PubMed ID: 10479284
[TBL] [Abstract][Full Text] [Related]
20. Enzyme inhibition, polyglutamation, and the effect of LY231514 (MTA) on purine biosynthesis.
Mendelsohn LG; Shih C; Chen VJ; Habeck LL; Gates SB; Shackelford KA
Semin Oncol; 1999 Apr; 26(2 Suppl 6):42-7. PubMed ID: 10598554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
